LEADER 01536nam  2200409   450 
001 9910706587203321
005 20171115101239.0
035   $a(CKB)5470000002456572
035   $a(OCoLC)1011593085
035   $a(EXLCZ)995470000002456572
100   $a20171115d2017      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPrescription opioids, Medicare needs to expand oversight efforts to reduce the risk of harm : report to congressional requesters
210  1$a[Washington, D.C.] :$cUnited States Government Accountability Office,$d2017.
215   $a1 online resource (ii, 30 pages) $ccolor illustrations
300   $a"October 2017."
300   $a"GAO-18-15."
320   $aIncludes bibliographical references.
517   $aPrescription opioids, Medicare needs to expand oversight efforts to reduce the risk of harm 
606   $aOpioid abuse$zUnited States
606   $aMedication abuse$zUnited States
606   $aNarcotics$xOverdose$zUnited States$xPrevention
606   $aHarm reduction$zUnited States
615  0$aOpioid abuse
615  0$aMedication abuse
615  0$aNarcotics$xOverdose$xPrevention.
615  0$aHarm reduction
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910706587203321
996   $aPrescription opioids, Medicare needs to expand oversight efforts to reduce the risk of harm : report to congressional requesters$93344993
997   $aUNINA